On February 25, 2020 Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, reported that the Company’s management team will participate in the following upcoming investor conferences (Press release, Hansa Biopharma, FEB 25, 2020, View Source [SID1234554681]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company’s 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, with a presentation at 4:10 PM EST/ 22:10 CET on the same day.
The Carnegie Nordic Healthcare Seminar in Stockholm on Wednesday, March 4, 2020, with a presentation at 8:00 AM CET
A live webcast of the Cowen presentation will be available on the Events & Webcast page of the Company’s website, www.hansabiopharma.com . A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

Calendar 2020

Feb 27-28, 2020

Road Show Cowen, Chicago/Dallas

Mar 2, 2020

Cowen Annual Health Care Conference, Boston

Mar 4, 2020

Road Show Argot, New York City

Mar 4, 2020

Carnegie Nordic Healthcare Seminar, Stockholm

Mar 26, 2020

Kempen Expert Call with Prof. Mårten Segelmark on Anti-GBM

Apr 2, 2020

Annual Report 2019

Apr 21-22, 2020

Kempen Life Sciences Conference, Amsterdam

Apr 28, 2020

Interim Report Jan-Mar 2020

May 5, 2020

Annual General Meeting

May 18, 2020

UBS Global Healthcare Conference, NYC

May 19, 2020

RBC Global Healthcare Conference, NYC

May 26, 2020

ABG Life Science Summit, Stockholm

May 27, 2020

Ökonomisk Ugebrev Life Science Conference, Copenhagen

Jul 16, 2020

Interimn Report Jan-Jul 2020

Sep 16-17, 2020

Bank of America Merill Lynch Global Healthcare Conf., London

Oct 22, 2020

Interimn Report Jan-Sep 2020

CONTACT:

For further information, please contact:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail: [email protected]

Rolf Gulliksen
Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 733-328 634
E-mail: [email protected]

This information was brought to you by Cision View Source

View Source,c3043193